Issue navigation
Volume 117, Issue 4, April 2025
Editorials
High-grade serous ovarian cancer after bilateral salpingo-oophorectomy
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 577–579, https://doi.org/10.1093/jnci/djae328
BRCA1/2 germline sequencing in children and adolescents with cancer: it is the context that matters
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 580–582, https://doi.org/10.1093/jnci/djae339
Active surveillance for prostate cancer: How active is too active?
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 583–585, https://doi.org/10.1093/jnci/djae342
Commentaries
Precision preclinical modeling to advance cancer treatment
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 586–594, https://doi.org/10.1093/jnci/djae249
The intersecting time, administrative, and financial burdens of a cancer diagnosis
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 595–600, https://doi.org/10.1093/jnci/djae252
Review
Utility of genomic testing in children, adolescents, and young adults with cancer
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 601–610, https://doi.org/10.1093/jnci/djae233
Articles
Effect of chemotherapy and surgery timing on mortality in upper and lower extremity osteosarcoma
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 611–618, https://doi.org/10.1093/jnci/djae229
Prediction of breast cancer risk for adolescents and young adults with Hodgkin lymphoma
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 619–628, https://doi.org/10.1093/jnci/djae274
Influence of endoxifen on mammographic density: results from the KARISMA-Tam trial
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 629–636, https://doi.org/10.1093/jnci/djae280
Supporting evidence in phase 2 cancer trial protocols: a content analysis
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 637–643, https://doi.org/10.1093/jnci/djae281
Impact of knowledge of human papillomavirus positivity on cervical cytology performance in Latin America
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 644–652, https://doi.org/10.1093/jnci/djae283
Impact of major depressive disorder on breast cancer outcomes: a national retrospective cohort study
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 653–664, https://doi.org/10.1093/jnci/djae287
Cumulative psychosocial and health disparities in US adolescent cigarette smoking, 2002-2019
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 665–672, https://doi.org/10.1093/jnci/djae286
Obesity-specific improvement of lung cancer outcomes and immunotherapy efficacy with metformin
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 673–684, https://doi.org/10.1093/jnci/djae295
Projected outcomes of reduced-biopsy management of Grade Group 1 prostate cancer: implications for relabeling
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 685–691, https://doi.org/10.1093/jnci/djae296
First cycle toxicity and survival in patients with rare cancers treated with checkpoint inhibitors
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 692–700, https://doi.org/10.1093/jnci/djae297
Proinflammatory dietary pattern and risk of total and subtypes of breast cancer among US women
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 701–712, https://doi.org/10.1093/jnci/djae301
The association of where patients with prostate cancer live and receive care on racial treatment inequities
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 713–718, https://doi.org/10.1093/jnci/djae302
High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 719–727, https://doi.org/10.1093/jnci/djae300
Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriers
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 728–736, https://doi.org/10.1093/jnci/djae306
State-level disparities in cervical cancer prevention and outcomes in the United States: a modeling study
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 737–746, https://doi.org/10.1093/jnci/djae298
Trends in cancer mortality under age 50 in 15 upper-middle and high-income countries
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 747–760, https://doi.org/10.1093/jnci/djae288
Liver elastography-based risk score for predicting hepatocellular carcinoma risk
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 761–771, https://doi.org/10.1093/jnci/djae304
Increased occurrence of malignancy before and after chemoradiation for anal squamous cell carcinoma: a multi-institutional analysis
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 772–780, https://doi.org/10.1093/jnci/djae309
Clinical and patient-reported outcomes after oncoplastic vs conventional breast-conserving surgery—a longitudinal, multicenter cohort study
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 781–789, https://doi.org/10.1093/jnci/djae310
Brief Communication
Implications of the initial Braidwood v. Becerra ruling for colorectal cancer outcomes: a modeling study
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 790–794, https://doi.org/10.1093/jnci/djae244
Consumption of aspartame and risk of breast cancer in the Nurses’ Health Studies
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 795–800, https://doi.org/10.1093/jnci/djae259
Correspondence
RE: Genetic risk, health-associated lifestyle, and risk of early-onset total cancer and breast cancer
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 801–802, https://doi.org/10.1093/jnci/djae322
Response to Zhang and Lv
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 803–804, https://doi.org/10.1093/jnci/djae323
RE: Effect of chemotherapy and surgery timing on mortality in upper and lower extremity osteosarcoma
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 805–806, https://doi.org/10.1093/jnci/djae332
Response to Liu, Xiao, Liu, et al.
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 807–808, https://doi.org/10.1093/jnci/djae333
Using GPT-4o to interpret patient-reported outcomes without training
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 809–811, https://doi.org/10.1093/jnci/djaf016
RE: Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriers
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 812–813, https://doi.org/10.1093/jnci/djaf027
Response to Kratz, Plon, and Lupo
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 814–815, https://doi.org/10.1093/jnci/djaf028
Stat Bite
Stat Bite: Variations in nasopharyngeal cancer incidence rates according to registries included in Cancer Incidence in Five Continents, Volume XII
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 4, April 2025, Pages 816–817, https://doi.org/10.1093/jnci/djaf029
